PCE Print, Nike Nosedive & A $14B Drug Deal 12/22/23

Carl Quintanilla and Leslie Picker tackle today’s biggest Money Movers including the Fed’s preferred inflation measure (PCE), Nike’s disappointing earnings print, and Bristol-Myers’ deal for Karuna Therapeutics.